79 related articles for article (PubMed ID: 32493821)
1. Differential Pressures of SERINC5 and IFITM3 on HIV-1 Envelope Glycoprotein over the Course of HIV-1 Infection.
Beitari S; Pan Q; Finzi A; Liang C
J Virol; 2020 Jul; 94(16):. PubMed ID: 32493821
[TBL] [Abstract][Full Text] [Related]
2. SERINC5 Inhibits HIV-1 Infectivity by Altering the Conformation of gp120 on HIV-1 Particles.
Featherstone A; Aiken C
J Virol; 2020 Sep; 94(20):. PubMed ID: 32796070
[TBL] [Abstract][Full Text] [Related]
3. SERINC5 Restricts HIV-1 Infectivity by Promoting Conformational Changes and Accelerating Functional Inactivation of Env.
Kirschman J; Marin M; Chen YC; Chen J; Herschhorn A; Smith AB; Melikyan GB
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891369
[TBL] [Abstract][Full Text] [Related]
4. IFITM1 and IFITM3 Proteins Inhibit the Infectivity of Progeny HIV-1 without Disrupting Envelope Glycoprotein Clusters.
Verma S; Chen YC; Marin M; Gillespie SE; Melikyan GB
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140631
[TBL] [Abstract][Full Text] [Related]
5. Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes.
Suddala KC; Lee CC; Meraner P; Marin M; Markosyan RM; Desai TM; Cohen FS; Brass AL; Melikyan GB
PLoS Pathog; 2019 Jan; 15(1):e1007532. PubMed ID: 30640957
[TBL] [Abstract][Full Text] [Related]
6. Alphavirus Restriction by IFITM Proteins.
Weston S; Czieso S; White IJ; Smith SE; Wash RS; Diaz-Soria C; Kellam P; Marsh M
Traffic; 2016 Sep; 17(9):997-1013. PubMed ID: 27219333
[TBL] [Abstract][Full Text] [Related]
7. Serinc5 Restricts HIV Membrane Fusion by Altering Lipid Order and Heterogeneity in the Viral Membrane.
Ward AE; Sokovikova D; Waxham MN; Heberle FA; Levental I; Levental KR; Kiessling V; White JM; Tamm LK
ACS Infect Dis; 2023 Apr; 9(4):773-784. PubMed ID: 36946615
[TBL] [Abstract][Full Text] [Related]
8. Human IFITM3 restricts chikungunya virus and Mayaro virus infection and is susceptible to virus-mediated counteraction.
Franz S; Pott F; Zillinger T; Schüler C; Dapa S; Fischer C; Passos V; Stenzel S; Chen F; Döhner K; Hartmann G; Sodeik B; Pessler F; Simmons G; Drexler JF; Goffinet C
Life Sci Alliance; 2021 Jul; 4(7):. PubMed ID: 34078739
[TBL] [Abstract][Full Text] [Related]
9. Beyond Impairment of Virion Infectivity: New Activities of the Anti-HIV Host Cell Factor SERINC5.
Sid Ahmed S; Bajak K; Fackler OT
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400059
[TBL] [Abstract][Full Text] [Related]
10. Structure dynamics of HIV-1 Env trimers on native virions engaged with living T cells.
Carlon-Andres I; Malinauskas T; Padilla-Parra S
Commun Biol; 2021 Oct; 4(1):1228. PubMed ID: 34707229
[TBL] [Abstract][Full Text] [Related]
11. A Long Cytoplasmic Loop Governs the Sensitivity of the Anti-viral Host Protein SERINC5 to HIV-1 Nef.
Dai W; Usami Y; Wu Y; Göttlinger H
Cell Rep; 2018 Jan; 22(4):869-875. PubMed ID: 29386131
[TBL] [Abstract][Full Text] [Related]
12. Further Characterization of the Antiviral Transmembrane Protein MARCH8.
Tada T; Zhang Y; Kong D; Tanaka M; Yao W; Kameoka M; Ueno T; Fujita H; Tokunaga K
Cells; 2024 Apr; 13(8):. PubMed ID: 38667313
[TBL] [Abstract][Full Text] [Related]
13. Disruption of Transmembrane Phosphatidylserine Asymmetry by HIV-1 Incorporated SERINC5 Is Not Responsible for Virus Restriction.
Raghunath G; Abbott EH; Marin M; Wu H; Reyes Ballista JM; Brindley MA; Melikyan GB
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785977
[TBL] [Abstract][Full Text] [Related]
14. The Antiviral Factor SERINC5 Impairs the Expression of Non-Self-DNA.
Shi Y; Simpson S; Ahmed SK; Chen Y; Tavakoli-Tameh A; Janaka SK; Evans DT; Serra-Moreno R
Viruses; 2023 Sep; 15(9):. PubMed ID: 37766367
[TBL] [Abstract][Full Text] [Related]
15. Metastable HIV-1 Surface Protein Env Sensitizes Cell Membranes to Transformation and Poration by Dual-Acting Virucidal Entry Inhibitors.
Ang CG; Hossain MA; Rajpara M; Bach H; Acharya K; Dick A; Rashad AA; Kutzler M; Abrams CF; Chaiken I
Biochemistry; 2020 Feb; 59(6):818-828. PubMed ID: 31942789
[TBL] [Abstract][Full Text] [Related]
16. Bat IFITM3 restriction depends on S-palmitoylation and a polymorphic site within the CD225 domain.
Benfield CT; MacKenzie F; Ritzefeld M; Mazzon M; Weston S; Tate EW; Teo BH; Smith SE; Kellam P; Holmes EC; Marsh M
Life Sci Alliance; 2020 Jan; 3(1):. PubMed ID: 31826928
[TBL] [Abstract][Full Text] [Related]
17. Single-cell glycolytic activity regulates membrane tension and HIV-1 fusion.
Coomer CA; Carlon-Andres I; Iliopoulou M; Dustin ML; Compeer EB; Compton AA; Padilla-Parra S
PLoS Pathog; 2020 Feb; 16(2):e1008359. PubMed ID: 32084246
[TBL] [Abstract][Full Text] [Related]
18. Role of Viral Envelope Proteins in Determining Susceptibility of Viruses to IFITM Proteins.
Marceau T; Braibant M
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400030
[TBL] [Abstract][Full Text] [Related]
19. Elucidating the Antiviral Mechanism of Different MARCH Factors.
Umthong S; Lynch B; Timilsina U; Waxman B; Ivey EB; Stavrou S
mBio; 2021 Mar; 12(2):. PubMed ID: 33653895
[TBL] [Abstract][Full Text] [Related]
20. Positive selection of HIV host factors and the evolution of lentivirus genes.
Bozek K; Lengauer T
BMC Evol Biol; 2010 Jun; 10():186. PubMed ID: 20565842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
